Arrhythmia Alliance News & Events
Interview with Trudie Lobban MBE, Founder & Trustee of Arrhythmia Alliance
Arrhythmia Alliance is a coalition of charities, patient groups, patients, carers, healthcare professionals, policy-makers, politicians, allied professionals and all those involved in the care of or affected by cardiac arrhythmias. Arrhythmia Alliance works in collaboration to improve diagnosis, treatment and quality of life for all those suffering with arrhythmias.
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE)
Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1–2% of the general population. Its prevalence varies between continents and ethnicity, but the estimated number of patients with AF worldwide might be between 30 and 100 million.1 This prevalence is expected to increase significantly in the next 30–50 years due to an ageing population, and increasing risk factors to develop AF, including arterial hypertension and diabetes.2–5 In all populations studied, both prevalence and incidence are higher in men than in women and increase with age.6
WORLD HEART RHYTHM WEEK 5-11 JUNE 2017 TAKE THE PULSE CHECK CHALLENGE – IT COULD SAVE YOUR LIFE
HIGH RISK AF PATIENTS DENIED ACCESS TO LIFE-SAVING TREATMENT
New patient survey results show 80% of AF patients say ‘YES’ to the freedom that INR self-monitoring gives them
The purpose of this survey was to help discover patient thoughts and opinions about INR self-monitoring versus clinic visits. Several trials have demonstrated that patient self-monitoring (PSM) by those on long term warfarin significantly improves time in therapeutic range (TTR) and leads to better management outcomes.
Arrhythmia Alliance Launches APPG-A
Arrhythmias are a critical health concern in the UK, but the necessary policy attention and resource focus is limited. There are many issues from a management and service provision perspective that need to be addressed for the benefit of patients and the NHS. A strong political voice is necessary to help raise these issues and help to effect positive change.
Combination of principal component analysis and optical-flow motion compensation for improved cardiac MR thermometry
The use of magnetic resonance (MR) thermometry for the monitoring of thermal ablation is rapidly expanding. However, this technique remains challenging for the monitoring of the treatment of cardiac arrhythmia by radiofrequency ablation due to the heart displacement with respiration and contraction. Recent studies have addressed this problem by compensating in-plane motion in real-time with optical-flow based tracking technique.
Arrhythmia Alliance Medical Director Named President Elect of British Heart Rhythm Society
Friday 21 October, Birmingham, UK: Arrhythmia Alliance is pleased to announce that its Medical Director, Professor Richard Schilling, St Bartholomew’s Hospital, London has been chosen as the next President of the British Heart Rhythm Society – the world’s first heart rhythm society established in 1976. This further reinforces the strong links between the UK’s leading Heart Rhythm Charity and the Cardiac Specialists professional organization, combining the voice of the patient with that of the physician.
Arrhythmia Alliance places 3000th Public Access Defibrillator on World Restart the Heart Day
“AEDs must be as commonplace as fire extinguishers and smoke alarms if we are to dramatically reduce the number of deaths from sudden cardiac arrest in the UK.”